Researcher.Life Logo

Hepatology Communications : Impact Factor & More

eISSN: 2471-254XpISSN: 2471-254X
JournalOpen Access

Key Metrics

CiteScore
7.7
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
Scite Index
0.91 5-Year SI
SNIP
1.26
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Hepatology Communications

Hepatology Communications Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher JOHN WILEY & SONS LTD
Language English
Frequency Monthly
Article Processing ChargesUSD 2700
Publication Time8
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorAmerican Association for the Study of Liver Diseases
FrequencyMonthly
Publication Start Year2017
Publisher URLVisit website
Website URLVisit website
Publication Details
Publication Time 8
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Hepatology Communications ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Hepatology Communications

High frequency of ABCB4 and ABCB11 gene variants in adult patients with idiopathic chronic or recurrent cholestasis
  • 1 Jan 2026
  • Hepatology Communications
Autoimmune liver diseases in Latin America: Current landscape and challenges
  • 12 Dec 2025
  • Hepatology Communications
Burden of primary sclerosing cholangitis in Sweden (2002–2020): Incidence, outcomes, healthcare utilization, and costs
  • 12 Dec 2025
  • Hepatology Communications
The alternative splicing landscape of hepatocellular carcinoma and its potential for HCC detection
  • 12 Dec 2025
  • Hepatology Communications
A novel cell-permeable LOXL2 inhibitor PAT-1251 potently suppresses biliary liver fibrosis via collagen crosslinking-dependent and -independent mechanisms
  • 12 Dec 2025
  • Hepatology Communications
Dual roles of T cells in metabolic dysfunction–associated steatohepatitis pathogenesis and liver fibrosis: From inflammation to therapeutic targets
  • 3 Dec 2025
  • Hepatology Communications
High frequency of ABCB4 and ABCB11 gene variants in adult patients with idiopathic chronic or recurrent cholestasis
  • 1 Jan 2026
  • Hepatology Communications
Autoimmune liver diseases in Latin America: Current landscape and challenges
  • 12 Dec 2025
  • Hepatology Communications
Burden of primary sclerosing cholangitis in Sweden (2002–2020): Incidence, outcomes, healthcare utilization, and costs
  • 12 Dec 2025
  • Hepatology Communications
The alternative splicing landscape of hepatocellular carcinoma and its potential for HCC detection
  • 12 Dec 2025
  • Hepatology Communications
A novel cell-permeable LOXL2 inhibitor PAT-1251 potently suppresses biliary liver fibrosis via collagen crosslinking-dependent and -independent mechanisms
  • 12 Dec 2025
  • Hepatology Communications
Dual roles of T cells in metabolic dysfunction–associated steatohepatitis pathogenesis and liver fibrosis: From inflammation to therapeutic targets
  • 3 Dec 2025
  • Hepatology Communications

FAQs on Hepatology Communications